
Rabimak L 75mg/20mg Capsule SR
Marketer
Makmaul Labocare
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Rabimak L 75mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication Gastro-L 75mg/20mg Sustained-Release Capsules. This medication lessens excessive stomach acid production and prevents its backflow into the esophagus. Dosage and duration for Gastro-L 75mg/20mg SR Capsules are determined by your physician; it can be taken with or without food. Treatment should continue as directed, as premature discontinuation may cause symptom recurrence and condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, abdominal discomfort, diarrhea, gas, constipation, headache, fatigue, and influenza-like symptoms. These are usually transient and self-limiting. Report any concerning side effects immediately. Dizziness and drowsiness are also possible; avoid driving or activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to potential drowsiness exacerbation. A fiber-rich diet, avoidance of trigger foods, increased fluid intake, and regular exercise may enhance treatment outcomes. Pre-treatment disclosure of kidney or liver conditions, pregnancy, pregnancy planning, or breastfeeding is essential.
Uses of Rabimak L 75mg/20mg Capsule SR
Managing gastroesophageal reflux, intestinal ulcers, and irritable bowel syndrome.
Major Benefits of Rabimak L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rabimak L 75mg/20mg SR Capsules. Ingest the capsule whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Rabimak L 75mg/20mg Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Rabimak L 75mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire capsule without chewing, crushing, or breaking it. Rabimak L 75mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Rabimak L 75mg/20mg Capsule SR works:
Each Rabimak L 75mg/20mg sustained-release capsule contains levosulpiride and rabeprazole, a dual-action medication.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rabimak L 75mg/20mg SR capsules with alcohol is not advised due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Rabimak L 75mg/20mg SR capsules during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Rabimak L 75mg/20mg sustained-release capsules with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Rabimak L 75mg/20mg SR Capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rabimak L 75mg/20mg SR capsules to individuals with renal impairment. Physician consultation is advised. Preliminary findings, however, indicate that use in such patients should be approached with caution.
LiverCAUTION
Patients with severe hepatic impairment should use Rabimak L 75mg/20mg sustained-release capsules cautiously. Dosage modification of Rabimak L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Rabimak L 75mg/20mg Capsule SR :
Should you forget a dose of Rabimak L 75mg/20mg SR Capsules, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabimak L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
